ARTICLE | Clinical News
PCK3145: Phase IIa data
June 13, 2005 7:00 AM UTC
Data from an open-label, dose-escalation, U.K. Phase IIa trial in 16 patients showed 7 patients had stable disease and 1 patient had a partial response after 2 cycles of treatment with IV PCK3145. A r...